Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor (original) (raw)

Nature volume 388, pages 674–678 (1997)Cite this article

Abstract

Adenosine is released from metabolically active cells by facilitated diffusion, and is generated extracellularly by degradation of released ATP. It is a potent biological mediator that modulates the activity of numerous cell types, including various neuronal populations, platelets, neutrophils and mast cells, and smooth muscle cells in bronchi and vasculature. Most of these effects help to protect cells and tissues during stress conditions such as ischaemia. Adenosine mediates its effects through four receptor subtypes: the A1, A2a, A2b and A3 receptors1. The A2a receptor (A2aR)2,3 is abundant in basal ganglia, vasculature and platelets, and stimulates adenylyl cyclase. It is a major target of caffeine, the most widely used psychoactive drug4. Here we investigate the role of the A2a receptor by disrupting the gene in mice. We found that A2aR-knockout (A2aR−/−) mice were viable and bred normally. Their exploratory activity was reduced, whereas caffeine, which normally stimulates exploratory behaviour, became a depressant of exploratory activity. Knockout animals scored higher in anxiety tests, and male mice were much more aggressive towards intruders. The response of A2aR−/−mice to acute pain stimuli was slower. Blood pressure and heart rate were increased, as well as platelet aggregation. The specific A2a agonist CGS 21680 lost its biological activity in all systems tested.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Olah, M. E. & Stiles, G. L. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 35, 581–606 (1995).
    Article CAS Google Scholar
  2. Libert, F. et al. Selective amplification and cloning of four new members of the G protein-coupled recptor family. Science 244, 569–572 (1989).
    Article ADS CAS Google Scholar
  3. Maenhaut, C. et al. RDC8 codes for an adenosine A2receptor with physiological constitutive activity. Biochem. Biophys. Res. Commun. 173, 1169–1178 (1990).
    Article CAS Google Scholar
  4. Fredholm, B. B. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol. Toxicol. 76, 93–101 (1995).
    Article CAS Google Scholar
  5. Fink, J. S. et al. Molecular cloning of the rat A2adenosine receptor: selective co-expression with D2dopamine receptors in rat striatum. Mol. Brain. Res. 14, 186–195 (1992).
    Article CAS Google Scholar
  6. Furlong, T. J., Pierce, K. D., Selbie, L. A. & Shine, J. Molecular characterization of a human brain adenosine A2receptor. Mol. Brain Res. 15, 62–66 (1992).
    Article CAS Google Scholar
  7. Weaver, D. R. A2aadenosine receptor gene expression in developing rat brain. Mol. Brain Res. 20, 313–327 (1993).
    Article CAS Google Scholar
  8. Höpker, V. H., Saffrey, M. J. & Burnstock, G. The neuritogenic effect of myenteric plexus on striatal neurones in co-culture involves nitric oxide. Neuroreport 6, 1153–1156 (1995).
    Article Google Scholar
  9. Schiffmann, S. N. & Vanderhaegheen, J. J. Adenosine A2receptors regulate the gene expression of striatopallidal and striatonigral neurons. J. Neurosci. 13, 1080–1087 (1993).
    Article CAS Google Scholar
  10. Balk, J. H. et al. Parkinsonian-like locomotor impairment in mice lacking dopamine D2receptors. Nature 377, 424–428 (1995).
    Article ADS CAS Google Scholar
  11. Grace, A. A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41, 1–24 (1991).
    Article CAS Google Scholar
  12. Nikodijeviç, O., Jacobson, K. A. & Daly, J. W. Locomotor activity in mice during chronic treatment with caffeine and withdrawal. Pharmacol. Biochem. Behav. 44, 199–216 (1993).
    Article Google Scholar
  13. File, S. E., Baldwin, H. A., Johnston, A. L. & Wilks, L. J. Behavioral effects of acute and chronic administration of caffeine in the rat. Pharmacol. Biochem. Behav. 30, 809–815 (1988).
    Article CAS Google Scholar
  14. Jain, N., Kemp, N., Adeyemo, O., Buchanan, P. & Stone, T. W. Anxiolytic activity of adenosine receptor activation in mice. Br. J. Pharmacol. 116, 2127–2133 (1995).
    Article CAS Google Scholar
  15. Saudou, F. et al. Enhanced aggressive behavior in mice lacking 5-HT1Breceptor. Science 265, 1875–1878 (1994).
    Article ADS CAS Google Scholar
  16. Palmour, R. M., Lipowski, C. J., Simon, C. K. & Ervin, F. R. Adenosine analogs inhibit fighting in isolated male mice. Life Sci. 44, 1293–1301 (1989).
    Article CAS Google Scholar
  17. Sawynok, J. & Yaksh, T. L. Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol. Rev. 45, 43–85 (1993).
    CAS PubMed Google Scholar
  18. Sweeney, M. I., White, T. D., Jhamandas, K. H. & Sawynok, J. Morphine releases endogenous adenosine from the spinal cord in vivo. Eur. J. Pharmacol. 141, 169–170 (1987).
    Article CAS Google Scholar
  19. De Lander, G. E. & Keil, G. J. Antinociception induced by intrathecal coadministration of selective adenosine receptor and selective opioid receptor agonists in mice. J. Pharmacol. Exp. Ther. 268, 943–951 (1994).
    CAS PubMed Google Scholar
  20. McQueen, D. S. & Ribeiro, J. A. Pharmacological characterization of the receptor involved in chemoexcitation induced by adenosine. Br. J. Pharmacol. 88, 615–620 (1986).
    Article CAS Google Scholar
  21. Cristalli, G. et al. Inhibition of platelet aggregation by adenosine receptor agonists. Naunyn. Schmiedebergs Arch. Pharmacol. 349, 644–650 (1994).
    Article CAS Google Scholar
  22. Dionisotti, S., Zocchi, C., Varani, K., Borea, P. A. & Ongini, E. Effects of adenosine derivatives on human and rabbit platelet aggregation. Correlation of adenosine receptor affinities and antiaggregatory activity. Naunyn. Schmiedebergs Arch. Pharmacol. 346, 673–676 (1994).
    Google Scholar
  23. Varani, K., Gessi, S., Dalpiaz, A. & Borea, P. A. Pharmacological and biochemical characterization of purified A2aadenosine receptors in human platelet membranes by [3H]-CGS 21680 binding. Br. J. Pharmacol. 117, 1693–1701 (1996).
    Article CAS Google Scholar
  24. Ongini, E. & Fredholm, B. B. Pharmacology of adenosine A2Areceptors. Trends Pharmacol. Sci. 17, 364–372 (1996).
    Article CAS Google Scholar
  25. Nagy, A., Rossant, J., Nagy, R., Abramow-Neverly, W. & Roder, J. C. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl Acad. Sci. USA 90, 8424–8428 (1993).
    Article ADS CAS Google Scholar
  26. Worst, W. & Joyner, A. L. in Gene Targeting, a Practical Approach (ed. Joyner, A. L.) 33–61 (Oxford University Press, Oxford, 1993).
    Google Scholar
  27. Schiffmann, S. N. & Vanderhaegheen, J. J. Ontogeny of gene expression of adenosine A2receptor in the striatum: early localization in the patch compartment. J. Comp. Neurol. 317, 117–128 (1992).
    Article CAS Google Scholar
  28. Costentin, J. et al. Dissociated effects of inhibitors of enkephalin-metabolising peptidases or naloxone on various nociceptive responses. Eur. J. Pharmacol. 123, 37–44 (1986).
    Article CAS Google Scholar

Download references

Acknowledgements

The R1 ES and STP cell lines were provided by A. Nagy and B. Colledge, respectively. We thank J.-F. Aubert for his help with the determination ofthe haemodynamic parameters; O. Le Moine, H. Louis, D. Penninck and C. Kucharzewski for discussion; and E. Bressy, M. J. Simons, E. Quertainmont and M. Verslype for technical assistance. This work was supported by the Belgian programme on Interuniversity Poles of Attraction initiated by the Belgian State, Prime Minister's Office, Federal Service for Science, Technology and Culture. It was also supported by the Fonds de la Recherche Scientifique Médicale of Belgium, the BIOMED2 programme, and the Foundation Médicale Reine Elisabeth. Scientific responsiblity belongs to the authors. C.L. and S.N.S. are Chercheurs Qualifiés of the Fonds National de la Recherche Scientifique.

Author information

Authors and Affiliations

  1. IRIBHN, Université Libre de Bruxelles, Campus Erasme, 808 route de Lennik, B-1070, Bruxelles, Belgium
    Catherine Ledent, Gilbert Vassart & Marc Parmentier
  2. Laboratoire de Recherche sur les Neuropeptides, Université Libre de Bruxelles, Campus Erasme, 808 route de Lennik, B-1070, Bruxelles, Belgium
    Serge N. Schiffmann & Jean-Jacques Vanderhaeghen
  3. Service de Génétique Médicale, Université Libre de Bruxelles, Campus Erasme, 808 route de Lennik, B-1070, Bruxelles, Belgium
    Gilbert Vassart
  4. IFRMP, Unité de Neuropsychopharmacologie Expérimentale, CNRS UPRESA 6036, Faculté de Médecine et de Pharmacie, Avenue de l'Université, 76803 Saint Etienne du Rouvray, France
    Jean-Marie Vaugeois, Malika El Yacoubi & Jean Costentin
  5. Division of Hypertension, Lausanne University Medical School, CH-1011 Lausanne, Switzerland
    Thierry Pedrazzini
  6. Department of Biochemistry, CRC Growth Factors, University of Oxford, South Parks Road, OX1 3QU, Oxford, UK
    John K. Heath

Authors

  1. Catherine Ledent
    You can also search for this author inPubMed Google Scholar
  2. Jean-Marie Vaugeois
    You can also search for this author inPubMed Google Scholar
  3. Serge N. Schiffmann
    You can also search for this author inPubMed Google Scholar
  4. Thierry Pedrazzini
    You can also search for this author inPubMed Google Scholar
  5. Malika El Yacoubi
    You can also search for this author inPubMed Google Scholar
  6. Jean-Jacques Vanderhaeghen
    You can also search for this author inPubMed Google Scholar
  7. Jean Costentin
    You can also search for this author inPubMed Google Scholar
  8. John K. Heath
    You can also search for this author inPubMed Google Scholar
  9. Gilbert Vassart
    You can also search for this author inPubMed Google Scholar
  10. Marc Parmentier
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toMarc Parmentier.

Rights and permissions

About this article

Cite this article

Ledent, C., Vaugeois, JM., Schiffmann, S. et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor.Nature 388, 674–678 (1997). https://doi.org/10.1038/41771

Download citation

This article is cited by